<DOC>
<DOCNO>EP-0628046</DOCNO> 
<TEXT>
<INVENTION-TITLE>
TRIAZOLOPYRIMIDIN DERIVATIVES AS ANTIOTENSIN II RECEPTOR ANTAGONISTS
</INVENTION-TITLE>
<CLASSIFICATIONS>A61P904	A61P4300	A61P900	A61P910	A61K31519	A61K31519	A61P4300	A61P900	A61K31535	C07D24900	C07D24912	A61P912	A61K31505	C07D48704	A61K31505	A61K31535	C07D48700	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61P	A61P	A61P	A61P	A61K	A61K	A61P	A61P	A61K	C07D	C07D	A61P	A61K	C07D	A61K	A61K	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61P9	A61P43	A61P9	A61P9	A61K31	A61K31	A61P43	A61P9	A61K31	C07D249	C07D249	A61P9	A61K31	C07D487	A61K31	A61K31	C07D487	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The present invention relates to derivatives having formula (I) and their tautomeric forms, as well as addition salts thereof and therapeutical utilization particularly for the treament and prevention of cardiovascular diseases particularly for the treatment and prevention of hypertension, cardiac insufficiency, arterial wall diseases particularly atherosclerosis.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
A triazolopyrimidine derivative, characterised in that it is of general
formula (I):



in which :

one of the radicals R
1
 and R
2
 represents

a lower alkyl radical having 1 to 6 carbon atoms ;
an ether radical of the formula -(CH
2
)
p
OR in which p is an integer
from 1 to 6 and R represents a lower alkyl radical having 1 to 6 carbon atoms or a

benzyl radical ; or
an alcohol radical of the formula -(CH
2
)
p
OH in which p is as
defined above ; and
the other radical R
1
 or R
2
 represents

a hydrogen atom ;
a halogen atom ;
a lower alkyl radical having 1 to 6 carbon atoms ; or
a radical selected from the group comprising the radicals N
3
, OR
4
,
SR
4
, NR
5
R
6
 and NH(CH
2
)
n
-NR
5
R
6
 ;

   in which :

R
4
 represents :

a hydrogen atom ;
a lower alkyl radical having 1 to 6 carbon atoms or a C
3
-C
7

cycloalkyl radical;
a (CH
2
)
m
-COOR' radical, m being an integer from 1 to 4, and R'
being a hydrogen atom or a lower alkyl radical having 1 to 6 carbon atoms ; or
a (CH
2
)
m
-O-R' radical, m and R' being as defined above ;
R
5
 and R
6
, which are identical or different, represent :

a hydrogen atom ; or
a lower alkyl radical having 1 to 6 carbon atoms or a C
3
-C
7
 
cycloalkyl radical;

or
R
5
 and R
6
, taken together with the nitrogen atom to which they are
attached, form a heterocycle selected from morpholine, pyrrolidine or piperidine ;

and

n is an integer from 1 to 4 ;
X and Y, which are different, represent :

in one case a nitrogen atom ; and
in the other case a C-R
7
 group, in which R
7
 represents
a hydrogen atom;
a lower alkyl radical having 1 to 6 carbon atoms or a C
3
-C
7

cycloalkyl radical;
a (CH
2
)
n'
OH radical in which n' is an integer from 0 to 4 ;
an SR' radical, R' being as defined above ; or
an NR
5
R
6
 radical in which R
5
 and R
6
, which are identical or
different, represent a hydrogen atom, a lower alkyl radical having 1 to 6 carbon

atoms or a C
3
-C
7
 cycloalkyl radical ; and
- R
3
 represents a radical of the formula :


in which :
Z represents CH or N or Z' represents S or O ;
R
11
 represents a hydrogen atom or a halogen atom ; and
R
12
 represents a tetrazole radical, CN, COOH or CONH
2
 ;

and its tautomeric forms, and its pharmaceutically acceptable addition salts.
The derivative according to claim 1, characterised in that it is of
general formula (I) given above in which :


one of the radicals R
1
 and R
2
 represents :

a lower alkyl radical having 1 to 6 carbon atoms ;
an ether radical of the formula -(CH
2
)
p
OR in which p is an integer
from 1 to 6 and R represents a lower alkyl radical having 1 to 6 carbon atoms or a

benzyl radical ; or
an alcohol radical of the formula -(CH
2
)
p
OH in which p is as
defined above ; and
the other radical R
1
 or R
2
 represents :

a hydrogen atom ;
a halogen atom;
a lower alkyl radical having 1 to 6 carbon atoms ; or
a radical selected from the group comprising the radicals N
3
, OR
4
,
SR
4
, NR
5
R
6
 and NH(CH
2
)
n
-NR
5
R
6
 ;

   in which :

R
4
 represents :

a hydrogen atom ; or
a (CH
2
)
m
-O-R' radical in which m is an integer from 1 to 4 and R'
represents a lower alkyl radical having 1 to 6 carbon atoms ;
R
5
 and R
6
, which are identical or different, represent :

a hydrogen atom; or
a lower alkyl radical having 1 to 6 carbon atoms ;

or
R
5
 and R
6
, taken together with the nitrogen atom to which they are
attached, form a heterocycle selected from morpholine, pyrrolidine or piperidine ;

and

n is an integer from 1 to 4 ;
X and Y, which are different, represent :

in one case a nitrogen atom ; and
in the other case a C-R
7
 group, in which R
7
 represents
a hydrogen atom;
a lower alkyl radical having 1 to 6 carbon atoms ;
a (CH
2
)
n'
OH radical in which n' is an integer from 0 to 4 ;
an SR' radical, R' being as defined above ; or
an NR
5
R
6
 radical in which R
5
 and R
6
, which are identical or
different, represent a hydrogen atom, or a lower alkyl radical having 1 to 6 carbon

atoms ; and
R
3
 represents one of the following radicals : 

The derivative according to claim 1 or 2, characterised in that R
1
 is
an n-propyl, n-butyl or N-diethylamino group.
The derivative according to any one of claims 1 to 3, characterised
in that R
2
 is a hydroxyl, n-propyl or N-diethylamino group.
The derivative according to any one of claims 1 to 4, characterised
in that R
3
 is a 2-(1H-tetrazol-5-yl)phenyl group.
The derivative according to any one of claims 1 to 5, characterised
in that X is a nitrogen atom.
The derivative according to any one of claims 1 to 6, characterised
in that Y represents a CH, C-CH
3
 or C-NH
2
 group.
The derivative according to claim 1 or 2, characterised in that R
1
 is
a lower alkyl radical having 1 to 6 carbon atoms, R
2
 is a hydroxyl group, R
3
 is a
2-(1H-tetrazol-5-yl)phenyl group, X represents a nitrogen atom and Y represents a

CH or C-CH
3
 group.
The derivative according to claim 1 or 2, characterised in that it is
the derivative :

5 -hydroxy-7-propyl-6-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]-1,2,4-triazolo[1,5-a]
pyrimidine
:


The derivative according to claim 1 or 2, characterised in that it is
selected from the derivatives of the formulae :


A method of preparing the compounds of formula (I) according to
any one of claims 1 to 10, characterised in that it comprises :


a) preparing a compound of formula (α):


in which :

X, Y and R
3
 are as defined in claim 1; and
A and B represent in one case a hydroxyl group or a lower alkyl radical having 1
to 6 carbon atoms, and in the other case a lower alkyl radical having 1 to 6 carbon

atoms or an ether radical of the formula -(CH
2
)
p
OR in which p is an integer from
1 to 6 and R represents a lower alkyl radical having 1 to 6 carbon atoms or a

benzyl radical,

by condensing a 3-amino-1,2,4-triazole of formula (II):


in which R
7
 is as defined in claim 1, with a derivative of formula (β) :


in which R'
1
 is a lower alkyl radical having 1 to 6 carbon atoms or an ether radical
of the formula -(CH
2
)
p
OR, in which p is an integer from 1 to 6 and R represents a
lower alkyl radical having 1 to 6 carbon atoms or a benzyl radical, R
8
 represents a
lower alkyl radical having 1 to 6 carbon atoms or a lower O-alkyl group having 1

to 6 carbon atoms, preferably methyl or ethyl, and R
3
 is as defined in claim 1,
in an aprotic solvent or in an acid solvent or even in an alcohol in the presence of 

the corresponding sodium or potassium alkylate, or even in pyridine or 2-methyl-5-ethylpyridine
in the presence or absence of 4-dimethylaminopyridine, at a

temperature between 50 and 200°C;
b) optionally, protecting the function carried by R
3
 according to a method known

per se ;
c) heating the derivative thus obtained from the derivative of formula (β), when
the latter is a ketoester, in an appropriate reagent for converting the hydroxyl

group represented by A or B into a chlorine atom ;
d) heating this chlorinated derivative in the presence of a nucleophile containing
nitrogen, oxygen or sulphur, under reflux in an alcohol or in an autoclave at

100°C, in the presence or absence of a base, to give a derivative of formula (α) in
which A and B have the same meanings as R
1
 and R
2
 respectively ;
e) optionally, deprotecting the function carried by R
3
 ;

e
1
) converting this function into an acid group ; or
e
2
) converting this function into a tetrazole group ; or
e
3
) converting this group to an amide group ; and
f) optionally, converting the resulting derivative into an addition salt.
A pharmaceutical composition with antagonistic activity towards
angiotensin II receptors which permits a favourable treatment and prevention of

cardiovascular diseases, especially hypertension, cardiac insufficiency and
diseases of the arterial wall, said composition being characterised in that it

contains a pharmaceutically effective amount of at least one compound of formula
(I) as defined in any one of claims 1 to 10, or one of its pharmaceutically

acceptable addition salts, which may or may not be incorporated in a
pharmaceutically acceptable excipient, vehicle or carrier.
A pharmaceutical composition with antiproliferative activity
which permits a favourable treatment and prevention of diseases of the arterial

wall, especially atherosclerosis, said composition being characterised in that it
contains a pharmaceutically effective amount of at least one compound of formula

(I) as defined in any one of claims 1 to 10, or one of its pharmaceutically
acceptable addition salts, which may or may not be incorporated in a

pharmaceutically acceptable excipient, vehicle or carrier.
</CLAIMS>
</TEXT>
</DOC>
